CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has … more

U.S. Food and Drug Administration (FDA) director Robert Califf noted before a House committee on April 11, 2024, that there is no justification for the U.S. Drug Enforcement Administration (DEA) to … more

Artificial intelligence (“AI”) technology has the potential to facilitate sustainability and boost profitability in the manufacturing space, an industry expert says. James Newman, head of … more

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering is comprised of shares of NRXP common stock … more

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be … more

VenHub, a pioneering division of Autonomous Solutions, Inc., today announced the landmark achievement of receiving over 800 pre-orders for its Smart Stores, heralding a transformative era in the … more